DBD (DBD)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$3.32B
EV / Sales0.86
EV / EBITDA9.73
EV / Operating Cash Flow12.51
EV / Free Cash Flow14.80

Return Metrics (TTM)

Return on Equity (ROE)10.59%
Return on Assets (ROA)2.98%
Return on Invested Capital (ROIC)9.23%
Return on Capital Employed (ROCE)13.27%

Yield Metrics

Earnings Yield4.39%
Free Cash Flow Yield8.99%

Balance Sheet Strength

Net Debt / EBITDA2.42
Current Ratio1.27
Working Capital$361.00M
Tangible Asset Value-$394.50M
Net Current Asset Value-$1.05B

Working Capital Efficiency

Days Sales Outstanding61.48
Days Payables Outstanding64.61
Operating Cycle (Days)137.54
Cash Conversion Cycle72.93

Capital Allocation

CapEx / Revenue1.06%
CapEx / Operating Cash Flow15.47%
R&D / Revenue2.17%
SG&A / Revenue12.15%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin26.37%
Operating Margin8.79%
Net Profit Margin2.49%

Solvency

Debt / Equity1.07
Quick Ratio0.92
Cash Ratio0.28

Per Share

Revenue / Share$103.42
FCF / Share$7.15
PE Ratio26.42